Summary
This will define the scope of disease spectrum, patient definition, list and prioritise the main challenges in disease to be addressed by the IRP and the LNHS, define outcomes/endpoints, and how to identify key risk predictors to identify patients that can qualify for future trials and assess potential biomarkers.
More information & hyperlinks